iShares Biotechnology ETF
710 hedge funds and large institutions have $6.41B invested in iShares Biotechnology ETF in 2019 Q4 according to their latest regulatory filings, with 171 funds opening new positions, 153 increasing their positions, 231 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
710
Holders Change
+113
Holders Change %
+18.93%
% of All Funds
14.02%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.22%
New
171
Increased
153
Reduced
231
Closed
48
Calls
$692M
Puts
$1.22B
Net Calls
-$524M
Net Calls Change
-$325M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$207M |
| 2 |
Goldman Sachs
New York
|
+$207M |
| 3 |
Citigroup
New York
|
+$166M |
| 4 |
Public Sector Pension Investment Board (PSP Investments)
Montreal,
Quebec, Canada
|
+$34.7M |
| 5 |
SMM
Stadion Money Management
Watkinsville,
Georgia
|
+$27.1M |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$224M |
| 2 |
JPMorgan Chase & Co
New York
|
-$195M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$170M |
| 4 |
N
Natixis
Paris,
France
|
-$125M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$68.9M |
